Voucher-based incentives for cigarette smoking reduction in a women's residential treatment program

Nicotine and Tobacco Research

Volumn 7, Issue 1, 2005, Pages 111-117

  Robles, Elias ^a   Crone, Cynthia C ^a   Whiteside Mansell, Leanne ^a   Conners, Nicola A ^a   Bokony, Patti A ^a   Worley, Linda L M ^a   McMillan, Donald E ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; COTININE;

ADULT; ARTICLE; BREATH ANALYSIS; FEE; FEMALE; HEALTH PROMOTION; HUMAN; NORMAL HUMAN; PATIENT MONITORING; PRIORITY JOURNAL; REINFORCEMENT; RESIDENTIAL CARE; REWARD; SMOKING CESSATION; TOBACCO;

ADULT; ANALYSIS OF VARIANCE; ARKANSAS; BREATH TESTS; CARBON MONOXIDE; FEMALE; HUMANS; MOTIVATION; RESIDENTIAL TREATMENT; SMOKING; SMOKING CESSATION; SUBSTANCE ABUSE TREATMENT CENTERS; TIME FACTORS; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 18144401226     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/14622200412331328448     Document Type: Article

References (38)

1. Budney, A. J., Higgins, S. T., Radonovich, K. J., & Novy, P. L. (2000). Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. Journal of Consulting & Clinical Psychology, 68, 1051-1061.
2. Carpenter, M., Hughes, J., & Keely, J. (2003). Effect of smoking reduction on later cessation: A pilot experimental study. Nicotine & Tobacco Research, 5, 155-163.
3. Centers for Disease Control and Prevention. (2000). Treating tobacco use and dependence. Fact Sheet, U.S. Public Health ServiceRetrieved September 21, 2004, from http://www.surgeongeneral.gov/tobacco/smokfact.htm
4. Centers for Disease Control and Prevention. (2002). Annual smoking-attributable mortality, years of potential life lost, and economic costs - United States, 1995-1999. Morbidity and Mortality Weekly Report, 51, 300-303.
5. Conners, N. A., Bradley, R. H., Whiteside-Mansell, L., & Crone, C. C. (2001). A comprehensive substance abuse treatment program for women and their children: An initial evaluation. Journal of Substance Abuse Treatment, 21, 67-75.
6. Dale, L. C., Glover, E. D., Sachs, D. P. L., Schroeder, D. R., Offord, K. P., Crogan, I. T., & Hurt, R. D. (2001). Bupropion for smoking cessation: Predictors of successful outcome. Chest, 119, 1357-1364.
7. Fagerström, K., & Schneider, N. G. (1989). Measuring nicotine dependence: A review of the Fagerström Tolerance Questionnaire. Journal of Behavioral Medicine, 12, 159-182,
8. Falkowski, C. (2003). Addressing nicotine addiction: When is the "right time"? Counselor, 4, 12-17.
9. Fiore, M. C., Bailey, W. C., Cohen, S. J., Dorfman, S. F., Gritz, E. R., Heyman, R. B., Holbrook, J., Jaen, C. R., Kottke, T. E., Lando, H. A., Mecklenbur, R., Mullen, P. D., Nett, L. M., Robinson, L., Stitzer, M., Tommasello, A. C., Villejo, L., & Wewers, M. E. (2000). Treating tobacco use and dependence. Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service.
10. Flock, J. A. (1995). Ready to quit: Making your plan to become a nonsmoker. Atlanta, GA: Prichet & Hull Associates.
11. Hann, D., Winter, K., & Jacobsen, P. (1999). Measurement of depressive symptoms in cancer patients: Evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). Journal of Psychosomatic Research, 46, 437-443.
12. Haustein, K. O., Haffner, S., & Woodcock, B. G. (2002). A review of the pharmacological and psychopharmacological aspects of smoking and smoking cessation in psychiatric patients. International Journal of Clinical Pharmacology & Therapeutics, 40, 404-418.
13. Hayford, K. E., Patten, C. A., Rummans, T. A., Schroeder, D. R., Offord, K. P., Croghan, I. T., Glover, E. D., Sachs, D. P. L., & Hurt, R. D. (1999). Effectiveness of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. British Journal of Psychology, 174, 173-178.
14. Hays, J. T., Hurt, R. D., Rigotti, N. A., Niaura, R., Gonzalez, D., Durcan, M. J., Sachs, D. P. L., Wolten, T. D., Buist, S. A., Johnston, J. A., & White, J. D. (2001). Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. Annals of Internal Medicine, 135, 423-433.
15. Heil, S., Tidey, J., Holmes, H., Badger, G., & Higgins, S. T. (2003). A contingent payment model of smoking cessation: Effects on abstinence and withdrawal. Nicotine & Tobacco Research, 5, 205.
16. Higgins, S. T., Budney, A. J., Bickel, W. K., Foerg, F. E., Donham, R., & Badger, G. J. (1994). Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Archives of General Psychiatry, 51, 568-576.
17. Higgins, S. T., Delaney, D., Budney, A. J., Bickel, W. K., Hughes, J. R., Foerg, F., & Fenwick, J. W. (1991). A behavioral approach to achieving initial cocaine abstinence. American Journal of Psychiatry, 148, 1218-1224.
18. Higgins, S. T., Heil, S. H., Lussier, J. P., Solomon, L., Abel, R. L., & McHale, L. (2002). Effects of abstinence-contingent vouchers on cigarette smoking among pregnant women. Drug and Alcohol Dependence, 66(Suppl. 1), S80.
19. Higgins, S. T., Heil, S. H., Solomon, L., Plebani-Lussier, J., Lynch, M. E., McHale, L., Simpson, L., & Glassman, P. (2003). Voucher-based incentives for abstinence from cigarette smoking in pregnant and postpartum women. Proceedings of the 65th Annual Meeting of the College on Problems of Drug Dependence, Miami, Florida, June 14-19.
20. Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., Croghan, I. T., & Sullivan, P. M. (1997). A comparison of sustained-release bupropion and placebo for smoking cessation. The New England Journal of Medicine, 337, 1195-1202.
21. Metsch, L. R., Rivers, J. E., Miller, M., Bohs, R., McCoy, C. B., Morrow, C. J., Bandstra, E. S., Jackson, V., & Gissen, M. (1995). Implementation of a family-centered treatment program for substance-abusing women and their children: Barriers and resolutions. Journal of Psychoactive Drugs, 27, 73-83.
22. Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
23. Roll, J. M., & Higgins, S. T. (2000). A within-subject comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. Drug and Alcohol Dependence, 58, 103-109.
24. Roll, J. M., Higgins, S. T., Steingard, S., & McGinley, M. (1998). Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: A feasibility study. Experimental and Clinical Psychopharmacology, 6, 157-161.
25. Schmitz, J. M., Rhoades, H., & Grabowski, J. (1995). Contingent reinforcement for reduced carbon monoxide levels in methadone maintenance patients. Addictive Behaviors, 20, 171-179.
26. Shoptaw, S., Jarvik, M. E., Ling, W., & Rawson, R. A. (1996). Contingency management for tobacco smoking in methadone-maintained opiate addicts. Addictive Behaviors, 21, 409-412.
27. Sigmon, S. C., Steingard, S., Badger, G. J., Anthony, S. L., & Higgins, S. T. (2000). Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: A feasibility study. Experimental and Clinical Psychopharmacology, 8, 507-517.
28. Silverman, K., Svikis, D., Robles, E., Stitzer, M. L., & Bigelow, G. E. (2001). A reinforcement-based therapeutic workplace for the treatment of drug abuse: Six-month abstinence outcomes. Experimental and Clinical Psychopharmacology, 9, 14-23.
29. Silverman, K., Wong, C. J., Higgins, S. T., Brooner, R. K., Montoya, I. D., & Contoreggi, C. (1996). Increasing opiate abstinence through voucher-based reinforcement therapy. Drug and Alcohol Dependence, 41, 157-165.
30. Srinivasan, T. N., & Thara, R. (2002). Smoking in schizophrenia - All is not biological. Schizophrenia Research, 56, 67-74.
31. Stitzer, M. L. (1999). Combined behavioral and pharmacological treatments for smoking cessation. Nicotine & Tobacco Research, 1(Suppl. 2), S181-S187; discussion, S207-S210.
32. Stitzer, M. L., & Bigelow, G. E. (1983). Contingent payment for carbon monoxide reduction: Effects of pay amount. Behavior Therapy, 14, 647-656.
33. Stitzer, M. L., & Bigelow, G. E. (1984). Contingent reinforcement for carbon monoxide reduction: Within-subject effects of pay amount. Journal of Applied Behavior Analysis, 17, 477-483.
34. Tidey, J. W., O'Neill, S. C., & Higgins, S. T. (2002). Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. Experimental & Clinical Psychopharmacology, 10, 241-247.
35. Wetter, D. W., Fiore, M. C., Gritz, E. R., Lando, H. A., Stitzer, M. L., Hasselblad, V., & Baker, T. B. (1998). The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline. Findings and implications for psychologists. American Psychologist, 53, 657-669.
36. Whiteside-Mansell, L., Crone, C. C., & Conners, N. A. (1999). The development and evaluation of an alcohol and drug prevention and treatment program for women and children. Journal of Substance Abuse Treatment, 16, 265-275.
37. Wiseman, E. J., & McMillan, D. E. (1998). Relationship of cessation of cocaine use to cigarette smoking in cocaine-dependent outpatients. American Journal of Drug and Alcohol Abuse, 24, 617-625.
38. Zickler, P. (2000). Nicotine craving and heavy smoking may contribute to increased use of cocaine and heroin. NIDA Notes, 15, 8-9.